Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process
- PMID: 19180636
- PMCID: PMC3905748
- DOI: 10.1002/cncr.24164
Postmastectomy radiotherapy for breast cancer: patterns, correlates, communication, and insights into the decision process
Abstract
Background: Given accumulating evidence supporting postmastectomy radiotherapy (PMRT) in selected patients, it is important to evaluate patterns and correlates of PMRT utilization, including communication and attitudinal factors.
Methods: The authors surveyed 2382 patients diagnosed with breast cancer in 2002 and reported to the Los Angeles and Detroit Surveillance, Epidemiology, and End Results registries (n=1844, 77.4% response rate). Analyses were restricted to patients with nonmetastatic invasive breast cancer treated by mastectomy who had decided whether or not to undergo PMRT (n=396). The authors assessed rates of explanation, recommendation, and receipt of radiation by indication grouping, defined primarily by the 2001 American Society of Clinical Oncology guidelines. They evaluated correlates of PMRT receipt, including tumor and sociodemographic characteristics. They also explored patients' self-reported reasons for nonreceipt of PMRT.
Results: The adjusted proportion in each indication group reporting that a provider had explained radiation was high (77% of those in whom PMRT was indicated, 76% of those in whom medical opinion was divided, and 73% of those in whom PMRT was not indicated; P=.10). The adjusted proportions reporting recommendations for radiation (86%, 35%, and 17%, respectively) and receipt (81%, 34%, and 10%, respectively) varied significantly by indication grouping (P<.001). On multivariate analysis, tumor size (P<.001), lymph node status (P<.001), comorbidity (P=.02), and chemotherapy receipt (P=.003) were found to be independent significant correlates of PMRT receipt. The most common reasons cited for not pursuing PMRT were lack of physician recommendation and perceived lack of need.
Conclusions: PMRT receipt is strongly correlated with clinical indication. The authors found no sociodemographic disparities in utilization. However, approximately one-fifth of patients with strong indications did not receive treatment.
Copyright (c) 2009 American Cancer Society.
Figures


Similar articles
-
Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer.J Clin Oncol. 2010 May 10;28(14):2396-403. doi: 10.1200/JCO.2009.26.8433. Epub 2010 Mar 29. J Clin Oncol. 2010. PMID: 20351324 Free PMC article.
-
Temporal Trends in Postmastectomy Radiation Therapy and Breast Reconstruction Associated With Changes in National Comprehensive Cancer Network Guidelines.JAMA Oncol. 2016 Jan;2(1):95-101. doi: 10.1001/jamaoncol.2015.3717. JAMA Oncol. 2016. PMID: 26539936 Free PMC article.
-
The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.Cancer. 2017 Aug 1;123(15):2829-2839. doi: 10.1002/cncr.30675. Epub 2017 Apr 7. Cancer. 2017. PMID: 28387923
-
Radiotherapy after skin-sparing mastectomy with immediate breast reconstruction in intermediate-risk breast cancer : Indication and technical considerations.Strahlenther Onkol. 2019 Nov;195(11):949-963. doi: 10.1007/s00066-019-01507-9. Epub 2019 Aug 26. Strahlenther Onkol. 2019. PMID: 31451835 Review. English.
-
Postmastectomy radiotherapy: indications and implications.Surgeon. 2014 Dec;12(6):310-5. doi: 10.1016/j.surge.2014.04.004. Epub 2014 Jul 16. Surgeon. 2014. PMID: 25037652 Review.
Cited by
-
Characteristics of older newly diagnosed cancer patients refusing cancer treatments.Support Care Cancer. 2010 Aug;18(8):969-74. doi: 10.1007/s00520-010-0883-0. Epub 2010 Apr 25. Support Care Cancer. 2010. PMID: 20419496
-
Patterns and correlates of adjuvant radiotherapy receipt after lumpectomy and after mastectomy for breast cancer.J Clin Oncol. 2010 May 10;28(14):2396-403. doi: 10.1200/JCO.2009.26.8433. Epub 2010 Mar 29. J Clin Oncol. 2010. PMID: 20351324 Free PMC article.
-
Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.JAMA Surg. 2014 Jun;149(6):582-9. doi: 10.1001/jamasurg.2013.5689. JAMA Surg. 2014. PMID: 24849045 Free PMC article.
-
Quality of life during the course of cancer treatment in older newly diagnosed patients. Results of a prospective pilot study.Ann Oncol. 2011 Apr;22(4):916-923. doi: 10.1093/annonc/mdq446. Epub 2010 Oct 5. Ann Oncol. 2011. PMID: 20924079 Free PMC article.
-
Reliability of reconstructed breast flap after chemotherapy and radiotherapy in immediate breast reconstruction.Arch Plast Surg. 2012 Sep;39(5):497-503. doi: 10.5999/aps.2012.39.5.497. Epub 2012 Sep 12. Arch Plast Surg. 2012. PMID: 23094245 Free PMC article.
References
-
- McArdle CS, Crawford D, Dykes EH, et al. Adjuvant radiotherapy and chemotherapy in breast cancer. Br J Surg. 1986;73:264–266. - PubMed
-
- Griem KL, Henderson IC, Gelman R, et al. The 5-year results of a randomized trial of adjuvant radiation therapy after chemotherapy in breast cancer patients treated with mastectomy. J Clin Oncol. 1987;5:1546–1555. - PubMed
-
- Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol. 1998;16:2625–2631. - PubMed
-
- Early Breast Cancer Trialists’ Collaborative Group Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet. 2000;355:1757–1770. - PubMed
-
- Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–955. - PubMed